ScholarLens Back to search
1990•Molecular PharmacologyRequires access

Development of a stable camptothecin-resistant subline of P388 leukemia with reduced topoisomerase I content.

Wai-Kwong Eng, F L McCabe, K. B. Tan, Michael R. Mattern, G A Hofmann, Richard Woessner, Robert Hertzberg, Richard K. Johnson

Open publisher page 127 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 127 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Camptothecin, Topoisomerase, Biology, Enzyme, Cell culture, In vitro, Biochemistry, Amsacrine

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
Development of a stable camptothecin-resistant subline of P388 leukemia with reduced topoisomerase I content. — Research Paper | ScholarLens